human granulocyte macrophage colony Search Results


human gm csf elisa kit  (Elabscience Biotechnology)
94
Elabscience Biotechnology human gm csf elisa kit
Pim1 promotes Th17 cell differentiation in vitro. (A) Relative mRNA levels of Pim1 during Th17 cell differentiation ( n = 9). (B) Relative protein levels of pSTAT3, RORγt, and Pim1 during Th17 cell differentiation ( n = 9). (C and D) Frequency of Th17 cells among CD4 + cells after AZD1208 treatment ( n = 9). (E) Relative protein levels of Pim1 among CD4 + T cells overexpressing (OE) vector or Pim1 ( n = 9). (F) Frequency of Th17 cells in CD4 + cells after overexpressing vector or Pim1 ( n = 9). (G) Relative protein levels of RORγt and pSTAT3 after AZD1208 treatment or Pim1 overexpression ( n = 9). (H and I) Relative mRNA levels of Th17-cell-associated pathogenic genes after AZD1208 treatment (H) or Pim1 overexpression (I) ( n = 9). (J and K) Concentration of IL-17A, IL-17F, IL-22, <t>and</t> <t>GM-CSF</t> in the cell supernatant after AZD1208 treatment (J) or Pim1 overexpression (K). (L) Frequencies of Th1, Th2, and Treg cells among CD4 + T cells after treatment with AZD1208 ( n = 9). The data were statistically analyzed via one-way ANOVA, followed by Bonferroni’s post hoc comparisons (A to D) and paired t test (E to L).
Human Gm Csf Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/Human+GM-CSF+(Granulocyte-Macrophage+Colony+Stimulating+Factor)+ELISA+Kit/pmc12946387-233-22-26
Average 94 stars, based on 1 article reviews
human gm csf elisa kit - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
bovine granulocyte macrophage colony stimulating factor  (MedChemExpress)
94
MedChemExpress bovine granulocyte macrophage colony stimulating factor
Pim1 promotes Th17 cell differentiation in vitro. (A) Relative mRNA levels of Pim1 during Th17 cell differentiation ( n = 9). (B) Relative protein levels of pSTAT3, RORγt, and Pim1 during Th17 cell differentiation ( n = 9). (C and D) Frequency of Th17 cells among CD4 + cells after AZD1208 treatment ( n = 9). (E) Relative protein levels of Pim1 among CD4 + T cells overexpressing (OE) vector or Pim1 ( n = 9). (F) Frequency of Th17 cells in CD4 + cells after overexpressing vector or Pim1 ( n = 9). (G) Relative protein levels of RORγt and pSTAT3 after AZD1208 treatment or Pim1 overexpression ( n = 9). (H and I) Relative mRNA levels of Th17-cell-associated pathogenic genes after AZD1208 treatment (H) or Pim1 overexpression (I) ( n = 9). (J and K) Concentration of IL-17A, IL-17F, IL-22, <t>and</t> <t>GM-CSF</t> in the cell supernatant after AZD1208 treatment (J) or Pim1 overexpression (K). (L) Frequencies of Th1, Th2, and Treg cells among CD4 + T cells after treatment with AZD1208 ( n = 9). The data were statistically analyzed via one-way ANOVA, followed by Bonferroni’s post hoc comparisons (A to D) and paired t test (E to L).
Bovine Granulocyte Macrophage Colony Stimulating Factor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/GM-CSF%2C+Human/pmc12466063-96-45-50
Average 94 stars, based on 1 article reviews
bovine granulocyte macrophage colony stimulating factor - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
human gm csf elisa kit  (Cusabio)
93
Cusabio human gm csf elisa kit
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Human Gm Csf Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/Human+Granulocyte-Macrophage+Colony+Stimulating+Factor%2CGM-CSF+ELISA+Kit/pmc11847672-113-1-6
Average 93 stars, based on 1 article reviews
human gm csf elisa kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
human gm csf  (Gold Biotechnology Inc)
90
Gold Biotechnology Inc human gm csf
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Human Gm Csf, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/CSF2+(GM-CSF)%2C+Human/bio_rxiv__779025-269-12-14
Average 90 stars, based on 1 article reviews
human gm csf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant human granulocyte-macrophage csf (gm-csf  (Schering-Plough corporation)
90
Schering-Plough corporation recombinant human granulocyte-macrophage csf (gm-csf
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Recombinant Human Granulocyte Macrophage Csf (Gm Csf, supplied by Schering-Plough corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/recombinant+human+granulocyte+macrophage+colony+stimulating+factor/10__1182_slash_blood__v91__9__3372-42-9-14
Average 90 stars, based on 1 article reviews
recombinant human granulocyte-macrophage csf (gm-csf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human granulocyte macrophage-colony stimulating factor molgramostin  (GENTAUR Inc)
90
GENTAUR Inc human granulocyte macrophage-colony stimulating factor molgramostin
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Human Granulocyte Macrophage Colony Stimulating Factor Molgramostin, supplied by GENTAUR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/human+granulocyte+macrophage+colony+stimulating+factor+molgramostin/pmc03922678-49-23-31
Average 90 stars, based on 1 article reviews
human granulocyte macrophage-colony stimulating factor molgramostin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human recombinant granulocyte macrophage colony-stimulating factor gm-csf leukine liquid sargramostim  (Berlex Laboratories Inc)
90
Berlex Laboratories Inc human recombinant granulocyte macrophage colony-stimulating factor gm-csf leukine liquid sargramostim
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Human Recombinant Granulocyte Macrophage Colony Stimulating Factor Gm Csf Leukine Liquid Sargramostim, supplied by Berlex Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/human+recombinant+granulocyte+macrophage+colony+stimulating+factor+gm+csf+leukine+liquid+sargramostim/pm19609282-33-12-23
Average 90 stars, based on 1 article reviews
human recombinant granulocyte macrophage colony-stimulating factor gm-csf leukine liquid sargramostim - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant human granulocyte-macrophage colony-stimulating factor (rhugm-csf)  (ImmunoTools)
90
ImmunoTools recombinant human granulocyte-macrophage colony-stimulating factor (rhugm-csf)
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (Rhugm Csf), supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/recombinant+human+granulocyte+macrophage+colony+stimulating+factor/pmc05286885-422-4-14
Average 90 stars, based on 1 article reviews
recombinant human granulocyte-macrophage colony-stimulating factor (rhugm-csf) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
recombinant human (rh) gm-csf  (Primmune Inc)
90
Primmune Inc recombinant human (rh) gm-csf
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Recombinant Human (Rh) Gm Csf, supplied by Primmune Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/recombinant+human+granulocyte+macrophage+colony+stimulating+factor++gm+csf+/pmc04002911-50-3-17
Average 90 stars, based on 1 article reviews
recombinant human (rh) gm-csf - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor  (Krinner GmbH)
90
Krinner GmbH polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
Polyethylene Glycol Conjugated Human Single Chain Antibody Neutralizing Granulocyte Macrophage Colony Stimulating Factor, supplied by Krinner GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/polyethylene+glycol+conjugated+human+single+chain+antibody+neutralizing+granulocyte+macrophage+colony+stimulating+factor/10__1158_slash_1535___7163__mct___21___0236-415-16-0
Average 90 stars, based on 1 article reviews
polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
30 ng/ml recombinant human granulocyte-macrophage colony-stimulating factor (rhgm-csf) (immunotoools, 11343125)  (ImmunoTools)
90
ImmunoTools 30 ng/ml recombinant human granulocyte-macrophage colony-stimulating factor (rhgm-csf) (immunotoools, 11343125)
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
30 Ng/Ml Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (Rhgm Csf) (Immunotoools, 11343125), supplied by ImmunoTools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/30+ng+ml+recombinant+human+granulocyte+macrophage+colony+stimulating+factor++rhgm+csf+++immunotoools++11343125+/pm33891922-78-50-66
Average 90 stars, based on 1 article reviews
30 ng/ml recombinant human granulocyte-macrophage colony-stimulating factor (rhgm-csf) (immunotoools, 11343125) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
50 ng/ml recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf; leukine)  (Bayer HealthCare Pharmaceuticals Inc)
90
Bayer HealthCare Pharmaceuticals Inc 50 ng/ml recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf; leukine)
Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via <t>ELISA</t> and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.
50 Ng/Ml Recombinant Human Granulocyte Macrophage Colony Stimulating Factor (Gm Csf; Leukine), supplied by Bayer HealthCare Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulocyte+macrophage+colony/50+ng+ml+recombinant+human+granulocyte+macrophage+colony+stimulating+factor++gm+csf++leukine+/pmc02668876-330-58-67
Average 90 stars, based on 1 article reviews
50 ng/ml recombinant human granulocyte-macrophage colony-stimulating factor (gm-csf; leukine) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Pim1 promotes Th17 cell differentiation in vitro. (A) Relative mRNA levels of Pim1 during Th17 cell differentiation ( n = 9). (B) Relative protein levels of pSTAT3, RORγt, and Pim1 during Th17 cell differentiation ( n = 9). (C and D) Frequency of Th17 cells among CD4 + cells after AZD1208 treatment ( n = 9). (E) Relative protein levels of Pim1 among CD4 + T cells overexpressing (OE) vector or Pim1 ( n = 9). (F) Frequency of Th17 cells in CD4 + cells after overexpressing vector or Pim1 ( n = 9). (G) Relative protein levels of RORγt and pSTAT3 after AZD1208 treatment or Pim1 overexpression ( n = 9). (H and I) Relative mRNA levels of Th17-cell-associated pathogenic genes after AZD1208 treatment (H) or Pim1 overexpression (I) ( n = 9). (J and K) Concentration of IL-17A, IL-17F, IL-22, and GM-CSF in the cell supernatant after AZD1208 treatment (J) or Pim1 overexpression (K). (L) Frequencies of Th1, Th2, and Treg cells among CD4 + T cells after treatment with AZD1208 ( n = 9). The data were statistically analyzed via one-way ANOVA, followed by Bonferroni’s post hoc comparisons (A to D) and paired t test (E to L).

Journal: Research

Article Title: Pim1 Serves as a Therapeutic Target for Inflammatory Arthritis via Mitochondrial Metabolism and Th17 Cell Differentiation

doi: 10.34133/research.1137

Figure Lengend Snippet: Pim1 promotes Th17 cell differentiation in vitro. (A) Relative mRNA levels of Pim1 during Th17 cell differentiation ( n = 9). (B) Relative protein levels of pSTAT3, RORγt, and Pim1 during Th17 cell differentiation ( n = 9). (C and D) Frequency of Th17 cells among CD4 + cells after AZD1208 treatment ( n = 9). (E) Relative protein levels of Pim1 among CD4 + T cells overexpressing (OE) vector or Pim1 ( n = 9). (F) Frequency of Th17 cells in CD4 + cells after overexpressing vector or Pim1 ( n = 9). (G) Relative protein levels of RORγt and pSTAT3 after AZD1208 treatment or Pim1 overexpression ( n = 9). (H and I) Relative mRNA levels of Th17-cell-associated pathogenic genes after AZD1208 treatment (H) or Pim1 overexpression (I) ( n = 9). (J and K) Concentration of IL-17A, IL-17F, IL-22, and GM-CSF in the cell supernatant after AZD1208 treatment (J) or Pim1 overexpression (K). (L) Frequencies of Th1, Th2, and Treg cells among CD4 + T cells after treatment with AZD1208 ( n = 9). The data were statistically analyzed via one-way ANOVA, followed by Bonferroni’s post hoc comparisons (A to D) and paired t test (E to L).

Article Snippet: Human IL-17A enzyme-linked immunosorbent assay (ELISA) kit (Elabscience, #E-EL-H5812), human IL-17F ELISA kit (Elabscience, #E-EL-H4193), human IL-22 ELISA kit (Elabscience, #E-EL-H0106), and human GM-CSF ELISA kit (Elabscience, #E-EL-H0081) were used.

Techniques: Cell Differentiation, In Vitro, Plasmid Preparation, Over Expression, Concentration Assay

Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via ELISA and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.

Journal: Frontiers in Endocrinology

Article Title: Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid

doi: 10.3389/fendo.2025.1525392

Figure Lengend Snippet: Workflow of the comprehensive analysis of inflammatory biomarkers of oocyte function. Olink PEA technology screening was applied to identify FF and serum protein changes during oocyte maturation, distinguishing subgroups through different ovarian reserves. After PCA analysis as quality control, we obtained the FF DEPs and serum DEPs. Bioinformatics analysis was performed for FF DEPs, including STRING analysis, GO term enrichment analyses, and pathway enrichment analyses. The correlations between the serum DEPs and clinical features were calculated. A Venn network was constructed among FF and serum DEPs, including different oocyte maturities and ovarian reserves. The OSM was validated via ELISA and evaluated via an ROC curve because it is the intersection of the Venn network. FF, follicular fluid; NOR, normal ovarian reserve; DOR, diminished ovarian reserve; PCA, principal component analysis; DEPs, differentially expressed proteins; GO, Gene Ontology; ROC, receiver operating characteristic.

Article Snippet: A human GM-CSF ELISA kit (CSB-E04568h; CUSABIO Co., Wuhan, China) and a human TNF-α ELISA kit (CSB-E04740h; CUSABIO Co., Wuhan, China) were used to assess protein levels in the FF.

Techniques: Control, Construct, Enzyme-linked Immunosorbent Assay

Clinical and laboratory characteristics of the patients included in the ELISA group.

Journal: Frontiers in Endocrinology

Article Title: Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid

doi: 10.3389/fendo.2025.1525392

Figure Lengend Snippet: Clinical and laboratory characteristics of the patients included in the ELISA group.

Article Snippet: A human GM-CSF ELISA kit (CSB-E04568h; CUSABIO Co., Wuhan, China) and a human TNF-α ELISA kit (CSB-E04740h; CUSABIO Co., Wuhan, China) were used to assess protein levels in the FF.

Techniques: Enzyme-linked Immunosorbent Assay